Psychiatric co-morbidity in multiple sclerosis: The risk of depression and anxiety before and after MS diagnosis

Multiple Sclerosis

Volumn 22, Issue 3, 2016, Pages 347-353

  Hoang, Huong ^a,b,c   Laursen, Bjarne ^d   Stenager, Elsebeth N ^a,b   Stenager, Egon ^a,c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Research Unit of Mental Health   (Denmark)

^c Department of Neurology ^*  (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

antidepressant; anxiety; depression; Multiple sclerosis; psychiatric comorbidity; SSRI; TCA

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; CLINICAL EXAMINATION; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; PRESCRIPTION; PREVALENCE; PSYCHIATRIC DIAGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SYMPTOMATOLOGY; ANXIETY; DRUG USE; RISK; CASE CONTROL STUDY; MIDDLE AGED; ODDS RATIO; PSYCHOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ODDS RATIO; PREVALENCE;

EID: 84986596852     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515588973     Document Type: Article

References (30)

1. Markowitz CE,. Multiple sclerosis update. Am J Manag Care 2013; 19 (Suppl): s294-300.
2. Siegert RJ, Abernethy DA,. Depression in multiple sclerosis: A review. J Neurol Neurosurg Psychiatry 2005; 76: 469-475.
3. Feinstein A,. Multiple sclerosis and depression. Mult Scler 2011; 17: 1276-1281.
4. Ghaffar O, Feinstein A,. The neuropsychiatry of multiple sclerosis: A review of recent developments. Curr Opin Psychiatry 2007; 20: 278-285.
5. Sadovnick AD, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology 1996; 46: 628-632.
6. Minden SL, Orav J, Reich P,. Depression in multiple sclerosis. Gen Hosp Psychiatry 1987; 9: 426-434.
7. Patten SB, Beck CA, Williams JV, et al. Major depression in multiple sclerosis: A population-based perspective. Neurology 2003; 61: 1524-1527.
8. Schiffer RB, Caine ED, Bamford KA, et al. Depressive episodes in patients with multiple sclerosis. Am J Psychiatry 1983; 140: 1498-1500.
9. Joffe RT, Lippert GP, Gray TA, et al. Mood disorder and multiple sclerosis. Arch Neurol 1987; 44: 376-378.
10. Wilken JA, Sullivan C,. Recognizing and treating common psychiatric disorders in multiple sclerosis. Neurologist 2007; 13: 343-354.
11. Feinstein A, O'Connor P, Gray T, et al. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Multiple Sclerosis 1999; 5: 323-326.
12. Giordano A, Granella F, Lugaresi A, et al. Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci 2011; 307: 86-91.
13. Dahl OP, Stordal E, Lydersen S, et al. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway. Mult Scler 2009; 15: 1495-1501.
14. Burns MN, Siddique J, Fokuo JK, et al. Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis. Rehabil Psychol 2010; 55: 255-262.
15. Bronnum-Hansen H, Stenager E, Nylev Stenager E, et al. Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 1457-1459.
16. Pompili M, Forte A, Palermo M, et al. Suicide risk in multiple sclerosis: A systematic review of current literature. J Psychosom Res 2012; 73: 411-417.
17. Stenager EN, Jensen B, Stenager M, et al. Suicide attempts in multiple sclerosis. Mult Scler 2011; 17: 1265-1268.
18. Hyllested K,. Disseminated Sclerosis in Denmark: Prevalence and Geographical Distribution. Copenhagen: J Jørgensen, 1956.
19. Milo R, Miller A,. Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev 2014; 13: 518-524.
20. Mors O, Perto GP, Mortensen PB,. The Danish Psychiatric Central Research Register. Scand J Public Health 2011; 39 (Suppl): 54-57.
21. Pedersen CB,. The Danish Civil Registration System. Scand J Public Health 2011; 39 (Suppl): 22-25.
22. Kildemoes HW, Sorensen HT, Hallas J,. The Danish National Prescription Registry. Scand J Public Health 2011; 39 (Suppl): 38-41.
23. Marrie RA, Horwitz R, Cutter G, et al. The burden of mental comorbidity in multiple sclerosis: Frequent, underdiagnosed, and undertreated. Mult Scler 2009; 15: 385-392.
24. Feinstein A, Magalhaes S, Richard JF, et al. The link between multiple sclerosis and depression. Nat Rev Neurol 2014; 10: 507-517.
25. Korostil M, Feinstein A,. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007; 13: 67-72.
26. Janssens AC, Buljevac D, van Doorn PA, et al. Prediction of anxiety and distress following diagnosis of multiple sclerosis: A two-year longitudinal study. Mult Scler 2006; 12: 794-801.
27. Nielsen NM, Bager P, Simonsen J, et al. Major stressful life events in adulthood and risk of multiple sclerosis. J Neurol Neurosurg Psychiatry 2014; 85: 1103-1108.
28. Olsen LR, Mortensen EL, Bech P,. Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand 2004; 109: 96-103.
29. Anens E, Emtner M, Zetterberg L, et al. Physical activity in subjects with multiple sclerosis with focus on gender differences: A survey. BMC Neurol 2014; 14: 47.
30. Jawahar R, Oh U, Yang S, et al. A systematic review of pharmacological pain management in multiple sclerosis. Drugs 2013; 73: 1711-22.